Physicochemical and toxicological profiling of ash from the 2010 and 2011 eruptions of Eyjafjallajökull and Grímsvötn volcanoes, Iceland using a rapid respiratory hazard assessment protocol

Environmental Research

Volumn 127, Issue , 2013, Pages 63-73

  Horwell, C J ^a   Baxter, P J ^b   Hillman, S E ^a   Calkins, J A ^c   Damby, D E ^a   Delmelle, P ^c,d   Donaldson, K ^e   Dunster, C ^f   Fubini, B ^g   Kelly, F J ^f   Le Blond, J S ^h,i   Livi, K J T ^j   Murphy, F ^e   Nattrass, C ^a   Sweeney, S ^k   Tetley, T D ^k   Thordarson, T ^l   Tomatis, M ^g  

^a DURHAM UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF YORK   (United Kingdom)

^d UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f KING'S COLLEGE LONDON   (United Kingdom)

^g UNIVERSITY OF TURIN   (Italy)

^h UNIVERSITY OF CAMBRIDGE   (United Kingdom)

ⁱ DEPARTMENT OF LIFE SCIENCES   (United Kingdom)

^j JOHNS HOPKINS UNIVERSITY   (United States)

^k NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^l Grant Institute of Earth Sciences   (United Kingdom)

more..

Author keywords

Eyjafjallaj kull; Gr msv tn; Iceland; Respiratory health; Volcano

Indexed keywords

ANTIOXIDANT; ASBESTOS; COPPER; HYDROGEN PEROXIDE; HYDROXYL RADICAL; INTERLEUKIN 6; INTERLEUKIN 8; MANGANESE; MONOCYTE CHEMOTACTIC PROTEIN 1; NICKEL; SILICON DIOXIDE; ZINC;

ANTIOXIDANT; ASH; EXPLOSIVE; GRAIN SIZE; HAZARD ASSESSMENT; HEALTH RISK; HYDROGEN PEROXIDE; HYDROXYL RADICAL; MINERALOGY; PARTICULATE MATTER; PUBLIC HEALTH; RISK ASSESSMENT; TOXICOLOGY; VOLCANIC ERUPTION;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; GRAIN; HEALTH HAZARD; HEMOLYSIS; HUMAN; HUMAN CELL; ICELAND; IN VITRO STUDY; INFLAMMATION; LEACHING; LUNG ALVEOLUS EPITHELIUM; LUNG TOXICITY; MINERALOGY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; TOXICOLOGY; VOLCANIC ASH; VOLCANO; WATER ANALYSIS;

EYJAFJALLAJÖKULL; GRÍMSVÖTN; ICELAND; RESPIRATORY HEALTH; VOLCANO;

AIR POLLUTANTS; CELL LINE; EPITHELIAL CELLS; HUMANS; HYDROXYL RADICAL; ICELAND; INFLAMMATION; INFLAMMATION MEDIATORS; LUNG; MINERALS; PARTICLE SIZE; RISK ASSESSMENT; SILICON DIOXIDE; TOXICITY TESTS; VOLCANIC ERUPTIONS;

ICELAND; LEEWARD ISLANDS [LESSER ANTILLES]; MONTSERRAT; SOUFRIERE HILLS VOLCANO;

EID: 84888356665     PISSN: 00139351     EISSN: 10960953     Source Type: Journal    
DOI: 10.1016/j.envres.2013.08.011     Document Type: Article

References (66)

1. Armienta M.A., et al. Chemical variations of tephra-fall deposit leachates for three eruptions from Popocatépetl volcano. Journal of Volcanology and Geothermal Research 2002, 113:61-80.
2. Ayres J.G., et al. Evaluating the toxicity of airborne particulate matter and nanoparticles by measuring oxidative stress potential-a workshop report and consensus statement. Inhalation Toxicology 2008, 20:75-99.
3. Baxter P.J., et al. Cristobalite in volcanic ash of the Soufriere Hills Volcano, Montserrat, British West Indies. Science 1999, 283:1142-1145.
4. Baxter P.J., et al. Mount St. Helens eruptions, May 18 to June 12, 1980: an overview of the health impact. Journal of the American Medical Association 1981, 248:2585-2589.
5. Baxter P.J., et al. Mount St. Helens eruptions: the acute respiratory effects of volcanic ash in a North American community. Archives of Environmental Health 1983, 38:138-143.
6. Baxter, P.J., et al., Evaluating the respiratory health risks of volcanic ash at the eruption of the Soufrière Hills Volcano, Montserrat, 1995-2010. In: Wadge, G., et al., (Eds.), Memoir of the Geological Society of London, vol. 39, in press. http://dx.doi.org/10.1144/M39.22.
7. Buist A.S., et al. A four-year prospective study of the respiratory effects of volcanic ash from Mt. St. Helens. American Review of Respiratory Disease 1986, 133:526-534.
8. Caboche J., et al. Development of an in vitro method to estimate lung bioaccessibility of metals from atmospheric particles. Journal of Environmental Monitoring 2011, 13:621-630.
9. Carlsen H.K., et al. A survey of early health effects of the Eyjafjallajökull 2010 eruption in Iceland: a population-based study. BMJ Open 2012, 2:e000343.
10. Carlsen H.K., et al. Health effects following the Eyjafjallajökull volcanic eruption: a cohort study. BMJ Open 2012, 2.
11. Christenson B.W. Geochemistry of fluids associated with the 1995-1996 eruption of Mt Ruapehu, New Zealand: signatures and processes in the magmatic-hydrothermal system. Journal of Volcanology and Geothermal Research 2000, 97:1-30.
12. Clouter A., et al. Inflammatory effects of respirable quartz collected in workplaces versus standard DQ12 quartz: particle surface correlates. Toxicological Sciences: An Official Journal of the Society of Toxicology 2001, 63:90-98.
13. Cronin S.J., et al. Agronomic impact of tephra fallout from 1995 and 1996 Ruapehu volcano eruptions, New Zealand. Environmental Geology 1998, 34:21-30.
14. Cullen, R.T., et al., 2002. Toxicity of volcanic ash from Montserrat. Institute of Occupational Medicine, Edinburgh. pp. 55.
15. Cullen, R.T., Searl, A., 1998. Preliminary toxicological hazard assessment of Montserrat volcanic ash: in vitro cytotoxicity. Institute of Occupational Medicine, Edinburgh. pp. 13.
16. Damby D.E., et al. The respiratory health hazard of tephra from the 2010 Centennial eruption of Merapi with implications for occupational mining of deposits. Journal of Volcanology and Geothermal Research 2013, 261:376-387.
17. Duffin R., et al. Aluminium lactate treatment of DQ12 quartz inhibits its ability to cause inflammation, chemokine expression, and nuclear factor-κB activation. Toxicology and Applied Pharmacology 2001, 176:10-17.
18. Duffin R., et al. The importance of surface area and specific reactivity in the acute pulmonary inflammatory response to particles. Annals of Occupational Hygiene 2002, 46:242-245.
19. Elliot A.J., et al. Syndromic surveillance to assess the potential public health impact of the Icelandic volcanic ash plume across the United Kingdom, April 2010. European Surveillance 2010, 15:6-9.
20. Forbes L., et al. Volcanic ash and respiratory symptoms in children on the island of Montserrat, British West Indies. Occupational and Environmental Medicine 2003, 60:207-211.
21. Fubini B., et al. Free radical generation at the solid/liquid interface in iron containing minerals. Free Radical Research 1995, 23:593-614.
22. Gudmundsson, M.T., et al., 2012a. The may 2011 eruption of Grímsvötn. EGU General Assembly. Geophysical Research Abstracts, Vienna, vol. 14. pp. EGU2012-12119.
23. Gudmundsson, M.T., et al., 2012b. Ash generation and distribution from the April-May 2010 eruption of Eyjafjallajökull. Iceland Scientific Reports. vol. 2, p. 572.
24. Hardy J.A., Aust A.E. Iron in asbestos chemistry and carcinogenicity. Chemical Reviews 1995, 95:97-118.
25. Hillman S.E., et al. Sakurajima volcano: a physico-chemical study of the health consequences of long-term exposure to volcanic ash. Bulletin of Volcanology 2012, 74:913-930.
26. Hincks T.K., et al. Long term exposure to respirable volcanic ash on Montserrat: a time series simulation. Bulletin of Volcanology 2006, 68:266-284.
27. Hinkley, T.K., Smith, K.S., 1982. Leachate chemistry of ash from the May 18, 1980 eruption of Mount. St. Helens. U.S. Geological Survey Professional Paper. 1397-B, pp. 27-64.
28. Horwell C.J. Grain size analysis of volcanic ash for the rapid assessment of respiratory health hazard. Journal of Environmental Monitoring 2007, 9:1107-1115.
29. Horwell C.J., Baxter P.J. The respiratory health hazards of volcanic ash: a review for volcanic risk mitigation. Bulletin of Volcanology. 2006, 69:1-24.
30. Horwell C.J., et al. Iron-induced hydroxyl radical generation from basaltic volcanic ash. Earth and Planetary Science Letters 2007, 261:662-669.
31. Horwell C.J., et al. Surface reactivity of volcanic ash from the eruption of Soufrière Hills Volcano, Montserrat, with implications for health hazards. Environmental Research 2003, 93:202-215.
32. Horwell, C.J., et al., Controls on variations in cristobalite abundance in ash generated by the Soufrière Hills volcano, Montserrat in the period 1997-2010. In: Wadge, G., et al., (Eds.), Memoir of the Geological Society of London, vol. 39, in press. http://dx.doi.org/10.1144/M39.21.
33. Horwell C.J., et al. Cristobalite in a rhyolitic lava dome: evolution of ash hazard. Bulletin of Volcanology 2010, 72:249-253.
34. Horwell C.J., et al. The characterisation of respirable volcanic ash from the Soufriere Hills Volcano, Montserrat, with implications for health hazard. Bulletin of Volcanology 2003, 65:346-362.
35. Horwell C.J., et al. A physico-chemical assessment of the health hazard of Mt. Vesuvius volcanic ash. Journal of Volcanology and Geothermal Research 2010, 191:222-232.
36. Horwell C.J., et al. The structure of volcanic cristobalite in relation to its toxicity; relevance for the variable crystalline silica hazard. Particle and Fibre Toxicology 2012, 9:44.
37. Horwell C.J., et al. Nature and formation of cristobalite at the Soufrière Hills Volcano, Montserrat: implications for the petrology and stability of silicic lava domes. Bulletin of Volcanology 2013, 75:696.
38. Housley D.G., et al. Pulmonary epithelial response in the rat lung to instilled Montserrat respirable dusts and their major mineral components. Occupational and Environmental Medicine 2002, 59:466-472.
39. Hughes J.M., et al. Radiographic evidence of silicosis risk in the diatomaceous earth industry. American Journal of Respiratory Critical Care Medicine 1998, 158:807-814.
40. Ilyinskaya E., et al. Near-source observations of aerosol size distributions in the eruptive plumes from Eyjafjallajökull volcano March-April 2010. Atmospheric Environment 2011, 45:3210-3216.
41. Kane A.B. Mechanisms of mineral fibre carcinogenesis. Mechanisms of Fibre Carcinogenesis 1996, 11-34. International Agency for Research on Cancer, Lyon. A.B. Kane (Ed.).
42. Kelly F.J., et al. Altered lung antioxidant status in patients with mild asthma. Lancet 1999, 354:482-483.
43. Kemp S.J., et al. Immortalization of human alveolar epithelial cells to investigate nanoparticle uptake. American Journal of Respiratory Cell and Molecular Biology 2008, 39:591-597.
44. Larsen G., et al. Eight centuries of periodic volcanism at the center of the Icelandic hotspot revealed by glacier tephrostratigraphy. Geology of Ore Deposits 1998, 26:943-946.
45. Le Blond J.S., et al. A rapid method for quantifying single mineral phases in heterogeneous natural dust using X-ray diffraction. Powder Diffraction 2009, 24:17-23.
46. Le Blond J.S., et al. Mineralogical analyses and in vitro screening tests for the rapid evaluation of the health hazard of volcanic ash at Rabaul volcano, Papua New Guinea. Bulletin of Volcanology 2010, 72:1077-1092.
47. Lee S.H., Richards R.J. Montserrat volcanic ash induces lymph node granuloma and delayed lung inflammation. Toxicology 2004, 195:155-165.
48. Lemire J., et al. Zinc toxicity alters mitochondrial metabolism and leads to decreased ATP production. Journal of Applied Toxicology 2008, 28:175-182.
49. Matsuzawa T., Ikarashi Y. Haemolysis of various mammalian erythrocytes in sodium chloride, glucose and phosphate-buffer solutions. Laboratory Animals 1979, 13:329-331.
50. Phalen R.F., et al. Tracheobronchial particle dose considerations for in vitro toxicology studies. Toxicological Sciences 2006, 92:126-132.
51. Reich M., et al. Formation of cristobalite nanofibers during explosive volcanic eruptions. Geology 2009, 37:435-438.
52. Rice T.M., et al. Differential ability of transition metals to induce pulmonary inflammation. Toxicology and Applied Pharmacology 2001, 177:46-53.
53. Ruenraroengsak P., et al. Respiratory epithelial cytotoxicity and membrane damage (holes) caused by amine-modified nanoparticles. Nanotoxicology 2012, 6:94-108.
54. Searl A., et al. Assessment of the exposure of islanders to ash from the Soufriere Hills volcano, Montserrat, West Indies. Occupational and Environmental Medicine 2002, 59:523-531.
55. Sigmundsson F., et al. Intrusion triggering of the 2010 Eyjafjallajökull explosive eruption. Nature 2010, 468:426-430.
56. Statistics Iceland,. 2012. http://www.statice.is/.
57. Stevenson, J.A., et al. Distal deposition of tephra from the Eyjafjallajökull 2010 summit eruption. Journal of Geophysical Research 117, B00C10.
58. Swain R.J., et al. Assessment of cell line models of primary human cells by Raman spectral phenotyping. Biophysical Journal 2010, 98:1703-1711.
59. Thordarson T., Hoskuldsson A. Postglacial volcanism in Iceland. Jökull 2008, 58:197-228.
60. Thorsteinsson T., et al. High levels of particulate matter in Iceland due to direct ash emissions by the Eyjafjallajökull eruption and resuspension of deposited ash. Journal of Geophysical Research: Solid Earth 2012, 117:B00C05.
61. Vallyathan V., et al. Mount St. Helens' volcanic ash: hemolytic activity. Environmental Research. 1983, 30:349-360.
62. van den Bogaard E.H.J., et al. Inflammatory response and barrier properties of a new alveolar type 1-like cell line (TT1). Pharmaceutical Research 2009, 26:1172-1180.
63. Wilson M.R., et al. In vitro toxicology of respirable Montserrat volcanic ash. Occupational and Environmental Medicine 2000, 57:727-733.
64. Witham C.S., et al. Volcanic ash leachates: a review and recommendations for sampling methods. Journal of Volcanology and Geothermal Research 2005, 141:299-326.
65. World Health Organization, 2000. Air quality guidelines for Europe, second ed. Copenhagen.
66. Yano E., et al. Chronic pulmonary effects of volcanic ash: an epidemiologic study. Archives of Environmental Health 1986, 41:94-99.